Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-cell Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02006485
What this trial is testing

Ublituximab in Combination With TGR-1202 +/- Ibrutinib or Bendamustine in Patients With B-cell Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaNon-Hodgkin's Lymphoma
TG Therapeutics, Inc. 160
Testing effectiveness (Phase 2)Looking for participantsNCT07042438
What this trial is testing

Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsRecurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma+3 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT06564038
What this trial is testing

AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Who this might be right for
Chronic Lymphocytic LeukaemiaSmall Lymphocytic LymphomaMantle-cell Lymphoma+2 more
AstraZeneca 408
Large-scale testing (Phase 3)UnknownNCT01657955
What this trial is testing

Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaLeukemiaNeoplasms
Shandong Lanjin Pharmaceuticals Co.,Ltd 96
Testing effectiveness (Phase 2)Study completedNCT00295932
What this trial is testing

Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 79
Testing effectiveness (Phase 2)Looking for participantsNCT07397832
What this trial is testing

CRP Regimen in Treating Elderly Patients With Previously Untreated Double-Positive DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Tianjin Medical University Cancer Institute and Hospital 58
Early research (Phase 1)UnknownNCT04384393
What this trial is testing

Safety and Efficacy of ThisCART19 in Patients With Refractory or Relapsed B Cell Malignancies

Who this might be right for
B Cell Malignancy
Fundamenta Therapeutics, Ltd. 30
Post-approval studies (Phase 4)Looking for participantsNCT06609304
What this trial is testing

Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Zhengzhou University 20
Testing effectiveness (Phase 2)UnknownNCT05749549
What this trial is testing

Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers

Who this might be right for
Advanced CancerFollicular LymphomaPeripheral T Cell Lymphoma+1 more
Shanghai Blueray Biopharma Co., Ltd. 191
Early research (Phase 1)Study completedNCT04067414
What this trial is testing

Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaTransformed Lymphoma+1 more
Institute of Hematology & Blood Diseases Hospital, China 12
Early research (Phase 1)Study completedNCT00642031
What this trial is testing

Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesLeukemia
Prescient Therapeutics, Ltd. 20
Early research (Phase 1)Ended earlyNCT04045028
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaB-Cell Lymphoma
Genentech, Inc. 41
Early research (Phase 1)Study completedNCT02924402
What this trial is testing

Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

Who this might be right for
B-cell Non-Hodgkins LymphomaChronic Lymphocytic Leukemia
Xencor, Inc. 154
Early research (Phase 1)Ended earlyNCT06254495
What this trial is testing

A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers

Who this might be right for
Hodgkin DiseaseLymphoma, T-Cell, PeripheralLymphoma, Large B-Cell, Diffuse+1 more
Seagen, a wholly owned subsidiary of Pfizer 58
Very early researchUnknownNCT04264039
What this trial is testing

Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic Malignancies

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB-cell Lymphoma
Xinqiao Hospital of Chongqing 30
Large-scale testing (Phase 3)Looking for participantsNCT06607419
What this trial is testing

Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia

Who this might be right for
B-Cell Lymphoblastic Leukemia
Shanghai Jiao Tong University School of Medicine 90
Post-approval studies (Phase 4)Not Yet RecruitingNCT04790045
What this trial is testing

Lymph Node Microenvironment Modifications in Patients With CLL Treated With Venetoclax-based Regimens

Who this might be right for
Chronic Lymphocytic Leukemia
Paolo Ghia 30
Not applicableLooking for participantsNCT03375619
What this trial is testing

Long-term Follow-up Study of Patients Receiving CAR-T Cells

Who this might be right for
Chronic Lymphocytic LeukemiaLymphomas Non-Hodgkin's B-CellLymphoma, Small Lymphocytic+6 more
Medical College of Wisconsin 500
Testing effectiveness (Phase 2)UnknownNCT05290337
What this trial is testing

ZR-CHOP in DLBCL With Specific Gene Abnormality

Who this might be right for
Diffuse Large B Cell Lymphoma
Fudan University 62
Testing effectiveness (Phase 2)Looking for participantsNCT06760039
What this trial is testing

Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma
Sun Yat-sen University 112
Next Page
56